Case Study: 503B Scales Up Capacity Without Compromising Quality

One of the biggest challenges for a Compounding Pharmacy is to increase production without compromising quality. Learn how one of the top 503B outsourcing facilities was able to scale up capacity while ensuring efficiency and patient safety by focusing on Quality Control Risk-Based Management. Their success includes strategies to leverage reliable rapid sterility test methods, such as solid-phase cytometry, for the safe release of compounded, ready-to-administer sterile injectable products. 

Watch the video of the presentation by Vivian D. Nguyen, QC Microbiology Supervisor, QuVa Pharma, at the 2023 Compounding Pharmacy Compliance conference, held in Boston.